Novo Integrated Sciences

Novo Integrated Sciences is a company listed under the stock ticker NVOS (US).

View the org chart displaying its 8 main executives

Most searched biographies at Novo Integrated Sciences

• Robert Mattacchione, Chief Executive Officer and Chairman of the B...
• Pierre Dalcourt, Director
• Joseph Chalil, Chief Medical Officer

Popular executive movements at Novo Integrated Sciences

• Robert Oliva, who was Director, is promoted to Director and President  (posted on February 18 2024).

Create your alert
to follow the executive moves at Novo Integrated Sciences.

Novo Integrated Sciences has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Novo Integrated Sciences

Social media about Novo Integrated Sciences

• Novo Integrated Sciences on Wikipedia, Google News & Yahoo Finance
• Novo Integrated Sciences on LinkedIn, Twitter & YouTube

Contact by email its executives including Pierre Dalcourt

Call Novo Integrated Sciences at +1 206...

View the org chart

Register to receive your alert

Report an error